| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:52:04 UTC |
|---|
| HMDB ID | HMDB0015661 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Fospropofol |
|---|
| Description | Fospropofol, also known as lusedra or aquavan, belongs to the class of organic compounds known as cumenes. These are aromatic compounds containing a prop-2-ylbenzene moiety. After in-vivo conversion of fospropofol into propofol by endothelial alkaline phosphatase, propofol crosses the blood-brain barrier, binds to GABA-A receptors and acts as an agonist. Fospropofol is a drug which is used for monitored anaesthesia care sedation in patients undergoing diagnostic procedures like bronchoscopy and colonscopy or minor surgical procedures like arthroscopy and bunionectomy. . Fospropofol is an extremely weak basic (essentially neutral) compound (based on its pKa). Unlike propofol, fospropofol is water soluble and can be administered in an aqueous solution. It is a prodrug and gets converted into Propofol in the liver. Overdosage may lead to cardiorespiratory depression, formic acid toxicity (methanol toxicity-like effects), and/or phosphate-induced hypocalemia. The metabolite, formaldehyde, is quickly oxidized into formic acid by glutathione dependent and independent dehydrogenases and erythrocytes. |
|---|
| Structure | CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16) |
|---|
| Synonyms | | Value | Source |
|---|
| Lusedra | HMDB | | Fospropofol disodium | HMDB | | Methanol, (2,6-bis(1-methylethyl)phenoxy)-, dihydrogen phosphate, disodium salt | HMDB | | Aquavan | HMDB | | {[2,6-bis(propan-2-yl)phenoxy]methoxy}phosphonate | Generator | | Fospropofol | MeSH |
|
|---|
| Chemical Formula | C13H21O5P |
|---|
| Average Molecular Weight | 288.2766 |
|---|
| Monoisotopic Molecular Weight | 288.112660294 |
|---|
| IUPAC Name | {[2,6-bis(propan-2-yl)phenoxy]methoxy}phosphonic acid |
|---|
| Traditional Name | fospropofol |
|---|
| CAS Registry Number | 258516-87-9 |
|---|
| SMILES | CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O |
|---|
| InChI Identifier | InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16) |
|---|
| InChI Key | QVNNONOFASOXQV-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cumenes. These are aromatic compounds containing a prop-2-ylbenzene moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Cumenes |
|---|
| Direct Parent | Cumenes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenylpropane
- Cumene
- Phenoxy compound
- Phenol ether
- Monoalkyl phosphate
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.19 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.8981 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.65 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 39.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1795.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 313.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 167.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 186.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 110.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 627.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 579.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 83.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1100.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 482.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1270.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 375.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 346.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 291.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 293.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Fospropofol,1TMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O[Si](C)(C)C | 1987.4 | Semi standard non polar | 33892256 | | Fospropofol,1TMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O[Si](C)(C)C | 1937.2 | Standard non polar | 33892256 | | Fospropofol,1TMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O[Si](C)(C)C | 2773.9 | Standard polar | 33892256 | | Fospropofol,2TMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2017.6 | Semi standard non polar | 33892256 | | Fospropofol,2TMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2032.5 | Standard non polar | 33892256 | | Fospropofol,2TMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 2441.8 | Standard polar | 33892256 | | Fospropofol,1TBDMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O[Si](C)(C)C(C)(C)C | 2242.4 | Semi standard non polar | 33892256 | | Fospropofol,1TBDMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O[Si](C)(C)C(C)(C)C | 2135.1 | Standard non polar | 33892256 | | Fospropofol,1TBDMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O[Si](C)(C)C(C)(C)C | 2889.6 | Standard polar | 33892256 | | Fospropofol,2TBDMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2474.6 | Semi standard non polar | 33892256 | | Fospropofol,2TBDMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2383.3 | Standard non polar | 33892256 | | Fospropofol,2TBDMS,isomer #1 | CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2682.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Fospropofol GC-MS (Non-derivatized) - 70eV, Positive | splash10-0002-9610000000-96197934c8dd427d84bc | 2017-08-28 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Fospropofol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 10V, Positive-QTOF | splash10-0002-9460000000-77d9f6f35e06e586586b | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 20V, Positive-QTOF | splash10-01ot-9830000000-6a695cd3d40280487012 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 40V, Positive-QTOF | splash10-01qa-9800000000-2ead84a2c2e827349728 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 10V, Negative-QTOF | splash10-000i-6190000000-ccb0ef8d15b189274cd5 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 20V, Negative-QTOF | splash10-004i-9000000000-a05f7f83bcc46e892604 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 40V, Negative-QTOF | splash10-004i-9000000000-f43f690bddd2f24c47c6 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 10V, Positive-QTOF | splash10-000i-2390000000-7c86240b3a58e75ab5a2 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 20V, Positive-QTOF | splash10-002r-1930000000-b89742e8a68fc5b76c46 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 40V, Positive-QTOF | splash10-000x-9810000000-29bec296079fdf66a1c7 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 10V, Negative-QTOF | splash10-000i-2090000000-079d943d19c33bea5398 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 20V, Negative-QTOF | splash10-004i-9000000000-2dd173dfe9a30642b89d | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fospropofol 40V, Negative-QTOF | splash10-004i-9000000000-5f4b7c7826ff5a7f1302 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Schywalsky M, Ihmsen H, Tzabazis A, Fechner J, Burak E, Vornov J, Schwilden H: Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats. Eur J Anaesthesiol. 2003 Mar;20(3):182-90. [PubMed:12650488 ]
- Garnock-Jones KP, Scott LJ: Fospropofol. Drugs. 2010 Mar 5;70(4):469-77. doi: 10.2165/11204450-000000000-00000. [PubMed:20205488 ]
- Bengalorkar GM, Bhuvana K, Sarala N, Kumar T: Fospropofol: clinical pharmacology. J Anaesthesiol Clin Pharmacol. 2011 Jan;27(1):79-83. [PubMed:21804712 ]
- Patwardhan A, Edelmayer R, Annabi E, Price T, Malan P, Dussor G: Receptor specificity defines algogenic properties of propofol and fospropofol. Anesth Analg. 2012 Oct;115(4):837-40. Epub 2012 May 14. [PubMed:22584560 ]
|
|---|